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Abstract
 
In the development of experimental autoimmune encephalomyelitis (EAE), a model for multiple
sclerosis (MS), autoreactive T cells must be activated and clonally expand in the lymphoid organs,
and then migrate into the central nervous system (CNS) where they undergo further activation. It
is unclear whether the autoreactive T cells further expand in the CNS and if so, what interactions
are required for this process. We have demonstrated previously that expression by the host cells
of the heat-stable antigen (CD24), which was recently identified as a genetic modifier for MS,
is essential for their susceptibility to EAE. Here we show that CD24 is essential for local clonal
expansion and persistence of T cells after their migration into the CNS, and that expression of
CD24 on either hematopoietic cells or nonhematopoietic antigen-presenting cells in the recipient
is sufficient to confer susceptibility to EAE.
Key words: costimulatory molecules • autoimmune diseases • central nervous system • 
multiple sclerosis • clonal expansion
 
Introduction
 
Induction of experimental autoimmune encephalomyelitis
(EAE) by pathogenic T cells is a multiple step process. The
autoreactive T cells are primed in the lymphoid organ by
immunization with myelin components. Activated myelin
antigen-specific T cells must penetrate the blood brain
barrier and be recruited into the central nervous system
(CNS) to exert their effector function. More recently, it
has been elegantly demonstrated that the autoreactive T
cells express new activation markers after their entry into
the CNS, presumably by interacting with local APCs (1–3).
It is unclear, however, whether the cells in the CNS un-
dergo further clonal expansion. This issue has an important
bearing on how the autoimmune disease is sustained in the
CNS, as T cells in the CNS appear to be prone to pro-
grammed cell death (4–7).
CD24 is a GPI-anchored cell surface glycoprotein and is
expressed in a broad range of cell types, including develop-
ing hematopoietic cells and mature B cells (8). It is also
known that CD24 is abundantly expressed in the CNS,
although its expression on the cells in the CNS that have
immune function has yet to be carefully defined. We have
reported that mice with a targeted mutation of CD24 are
resistant to the induction of both actively induced and
adoptively transferred autoreactive T cells and that the de-
velopment of EAE requires a functional CD24 gene in
both T cells and non–T host cells (9). More recently, our
genetic analysis revealed that CD24 polymorphism is a genetic
modifier for risk and progression of multiple sclerosis (MS;
reference 10). Because CD24 is a costimulatory molecule
that functions independently of CD28 (11–15), it is possi-
ble that CD24 in the CNS mediates local costimulation of
T cells. Alternatively, CD24 also modulates very late antigen
(VLA)4–vascular cell adhesion molecule (VCAM)-1 inter-
action (16) that regulates T cell recruitment to the CNS
(17). Therefore, CD24 may regulate the recruitment of au-
toreactive T cells to the CNS.
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To test these two hypotheses, we adoptively transferred
myelin oligodendrocyte glycoprotein (MOG)-reactive T
cells into WT and CD24
 
 
 
/
 
  
 
mice, and analyzed the re-
cruitment of T cells. We found that although the patho-
genic T cells can be recruited at a comparable efficiency to
the CNS of the WT and CD24
 
 
 
/
 
  
 
mice, the T cells persist
and expand only in WT CNS. In consistency with this, we
found that susceptibility to adoptively transferred T cells
can be conferred by cells of either hematopoietic or nonhe-
matopoietic origin. Interestingly, CD24 deficiency signifi-
cantly reduced the in vitro costimulatory activity of micro-
glia and astrocytes, two major APCs in the CNS, and that
the CD24 deficiency in the hosts leads to a significantly re-
duced local proliferation in the CNS. Finally, we found
that expression of CD24 does not affect apoptosis of T cells
in the CNS. These results demonstrate that CD24 controls
a novel checkpoint for EAE, most likely by controlling lo-
cal proliferation of autoreactive T cells in the CNS.
 
Materials and Methods
 
Mice.
 
CD24-deficient mice were produced using embryonic
stem cells from C57BL6/j mice as described previously (18).
C57BL6/j mice were purchased from the National Cancer Insti-
tute. All mice were maintained in animal facilities at the Ohio
State University Medical Center under specific pathogen-free
conditions. Thy1.1 congenic mice were purchased from The
Jackson Laboratory.
 
Bone Marrow Chimera Mice.
 
Bone marrow cells were isolated
by flushing femur and tibia bones with PBS. Recipient mice
were lethally irradiated (1,000 rads) and constituted with 10–
20 
 
  
 
10
 
6 
 
bone marrow cells by intravenous injection. Engraft-
ment took place over a 6–8-wk period.
 
Culture Medium and Reagents.
 
Click’s EHAA medium sup-
plemented with 10% FCS, 2 mM 
 
l
 
-glutamine, 100 
 
 
 
g/ml peni-
cillin/streptomycin, and 1 mM 2-ME were used for all lymph
node T cell cultures. For culture of glial cells, DMEM supple-
mented with 10% FCS, 2 mM 
 
l
 
-glutamine, and 100 
 
 
 
g/ml pen-
icillin/streptomycin was used. Recombinant murine IFN-
 
 
 
, IL-12,
and recombinant human IL-2 were purchased from PeproTech.
The immunogen MOG peptide 35–55 (MEVGWYRSPFSRV-
VHLYRNGK) was purchased from Genemed Synthesis, Inc. The
purity of the peptide was 
 
 
 
90%.
 
Adoptive Transfer EAE.
 
8–12-wk-old C57BL/6j or B6.PL/J
(Thy1.1) mice were immunized subcutaneously with 100 
 
 
 
g
MOG peptide in CFA in a total volume of 100 
 
 
 
l. 10 d after
immunization, draining lymph nodes were harvested and stimu-
lated at a density of 2 
 
  
 
10
 
6
 
/ml in Click’s EHAA medium sup-
plemented with 15% FCS, 20 ng/ml recombinant IL-12, and 50
 
 
 
g/ml MOG peptide for 4 d. Two different protocols were
used in this study. Protocol A was used for most of the studies,
except for those described in Fig. 7, which used protocol B.
Protocol A: 10 
 
  
 
10
 
6 
 
MOG peptide–activated lymph node cells
were injected i.v. into each recipient mouse in a total volume of
200 
 
 
 
l PBS. Each mouse received 160 ng of pertussis toxin
(Sigma-Aldrich) in 200 
 
 
 
l PBS in the tail vein immediately after
the cell transfer and again 48 h later. Protocol B: 20–50 
 
  
 
10
 
6
 
MOG-activated T cells were injected i.p. into each recipient
mouse that had been 
 
  
 
irradiated (350 rads) 1 h earlier. The
mice were observed every day and scored on a scale of 0–5 with
gradations of 0.5 for intermediate scores: 0, no clinical signs; 1,
loss of tail tone; 2, wobbly gait; 3, hind limb paralysis; 4, mori-
bund; and 5, death.
 
Immunohistochemistry.
 
Frozen sections of brain or spinal cords
were fixed with acetone and incubated with anti-CD3 (2C11)
and/or biotinylated anti-Thy1.1 (OX-7; BD Biosciences). After
extensive washes, the mAbs were detected by biotinylated goat
anti–rat mAbs followed by horseradish peroxidase–conjugated
streptavidin, whose deposition was visualized upon incubation
with DAB (3, 3
 
 
 
-diaminobenzidine) substrate.
 
RNase Protection Assay (RPA).
 
Total RNA from each indi-
vidual brain was isolated with Trizol reagent (Life Technologies).
The concentration of RNA in each sample was assessed by spec-
trophotometry. The multiprobe RPA kit (RiboQuant; BD Bio-
sciences) was used with the assay performed according to the
manufacturer’s protocol. In brief, a set of 
 
32
 
P-labeled RNA
probes synthesized from DNA templates using T7 polymerase
was hybridized with 20 
 
 
 
g total RNA, after which free probes
and other single strand RNA were digested with RNase. The re-
maining RNase-protected probes were purified, and then re-
solved on denaturing polyacrylamide gels. The template set mCD1
for mouse cell surface antigen was used in this study, which de-
tects mRNA of TCR-
 
 
 
, TCR-
 
 
 
, CD3
 
 
 
, CD4, CD8
 
 
 
, CD8
 
 
 
,
CD19, F4/80, CD45, L32, and GAPDH. For the detection of
cytokines, we used template set mCK3b, which detects mRNA
of TNF-
 
 
 
, LT
 
 
 
, TNF-
 
 
 
, IL-6, IFN-
 
 
 
, IFN-
 
 
 
, TGF-
 
 
 
1, TGF-
 
 
 
2,
TGF-
 
 
 
3, MIF, L32, and GAPDH.
 
Isolation of Mononuclear Cells from the CNS.
 
Fresh brain or spi-
nal cord tissues were removed from mice and cut into 
 
 
 
2-mm
pieces and incubated in 10 mM Hepes/NaOH buffer containing
1mg/ml of collagenase (Sigma-Aldrich) for 1 h at 37
 
 
 
C. The tissues
were dispersed with a syringe, filtered through a 100-mm wire
mesh, and centrifuged at 2,000 rpm for 5 min at 4
 
 
 
C. After centrif-
ugation, cell pellets were resuspended in 15 ml of 30% Percoll
(Amersham Biosciences), and centrifuged against 70% Percoll in a
50-ml tube for 15 min. The cell monolayer at the 30–70% Percoll
interface was collected and washed once for further staining.
 
Culture of Microglia and Astrocytes from Brains of Newborn Mice.
 
Primary glial cell cultures were prepared from brains of newborn
CD24
 
 
 
/
 
  
 
or CD24
 
 
 
/
 
  
 
mice as described previously (19, 20). In
brief, after removal of the meninges, the brains were mechani-
cally dissociated by nylon sieves. The cells were seeded in culture
medium (DMEM) containing 20% FCS in 75 cm
 
2 
 
tissue culture
flasks. On day 4 the medium was replaced with DMEM contain-
ing 10% FCS and medium was changed every 3 d thereafter. For
isolation of microglial cells, confluent cultures between days 12
and 14 were vigorously shaken and the floating cells were col-
lected and incubated at 37
 
 
 
C in flasks for another 2 h. The cul-
tures were then shaken at 90 rpm and the nonadherent cells were
washed out. The adherent cells were identified as microglial cells
by positive staining with isolectin IB4 conjugated with Alexa
Fluor 488 (Molecule Probes) and anti-CD45 antibodies (BD
Biosciences). The firmly adherent cells were stained with anti–
glial fibrillary acidic protein (GFAP) antibody to confirm their
identity as astrocytes (21).
 
MOG-specific T Cell Line.
 
Draining lymph node cells were
isolated 10 d after immunization of C57BL6 mice with MOG
peptide. 2 
 
  
 
10
 
6 
 
cells/ml were stimulated with 50 
 
 
 
g/ml MOG
peptide in the presence of 20 ng/ml IL-12 for 4 d. The viable
cells were isolated and cultured in Click’s EHAA medium in the
presence of 5 ng/ml recombinant human IL-2 for another 2 wk
before they were used for the proliferation assay.
 
Antibodies and Flow Cytometry.
 
FITC- or PE-conjugated an-
tibodies against CD3 (2C11), CD80 (16-10A), CD86 (GL1), 
Bai et al.
 
449
 
CD24 (M1/69), D
 
b 
 
(KH95) I-A
 
b 
 
(AF6-120), IFN-
 
  
 
(XMG1.2),
IL-4 (11B11), and rat IgG1 isotype control were all purchased
from BD Biosciences. APC-Thy1.1 (HIS51) was purchased
from eBioscience. Alexa Fluor 488–labeled isolectin IB4 was
purchased from Molecular Probes. Purified mouse anti-GFAP
cocktail was purchased from BD Biosciences. The antibody
against CD24 (20C9) has been described (11). For cell surface
staining, cells were incubated with antibodies in staining buffer
for 30 min on ice. Cells were then washed three times and fixed.
For intracellular staining of GFAP, astrocytes were first fixed
with Cytofix/Cytoperm buffer (BD Biosciences) followed by
washing with Perm/Wash buffer (BD Biosciences), and incu-
bated with anti-GFAP in Perm/Wash buffer for 30 min on ice.
After washing with Perm/Wash, cells were incubated with
FITC-conjugated rabbit anti–mouse IgG antibody (Accurate
Chemical & Scientific Corp.). For the staining of intracellular
cytokines, lymphocytes were incubated with GolgiStop (BD
Biosciences) in the last 5 h of culture. Viable cells were first fixed
in the Cytofix/Cytoperm buffer followed by staining with PE-
labeled anti–mouse cytokine antibodies and isotype control in
Perm/Wash buffer. Cells were analyzed on a FACSCalibur™
cytometer (Becton Dickinson).
To analyze T cell apoptosis, mononuclear cells isolated from the
CNS of WT or CD24
 
 
 
/
 
  
 
mice were stained with anti-Thy1.1 an-
tibody in conjunction with 7-AAD and FITC-labeled annexin V.
The annexin V
 
  
 
7AAD
 
  
 
cells are at late stages of apoptosis, whereas
the annexin V
 
  
 
7AAD
 
  
 
cells are at early stages of apoptosis.
 
Bromodeoxyuridine (BrdU) Incorporation.
 
MOG-specific T cells
were injected into mice i.v. At various times after adoptive trans-
fer, mice were given an i.p. injection of 1 mg BrdU (BD Bio-
sciences). 12 h later, mice were killed and perfused with PBS
through the left ventricle. The brain and spinal cord were re-
moved from each mouse. Mononuclear cells were prepared from
the brain and spinal cord, and were stained with anti-BrdU anti-
body using a BD Biosciences kit.
 
T Cell Proliferation Assay.
 
To assess the antigen-presenting
functions of cultured astrocytes and microglia, the WT MOG-
specific T cell line was used as a responder. In brief, irradiated
(3,000 rads) astrocytes or microglia were cultured in round-bot-
tomed microtiter plates in 200 
 
 
 
l DMEM medium containing
100 U/ml IFN-
 
 
 
. 3 d later, the medium was removed and 2–5 
 
 
 
10
 
4 
 
T cells in Click’s EHAA medium and the indicated concen-
trations of MOG peptide were added into each well. After 48 h,
the cultures were pulsed with 1 
 
 
 
Ci/well [
 
3
 
H]thymidine (ICN
Pharmaceuticals) for another 12 h, and incorporation of [
 
3
 
H]thy-
midine was measured in a liquid scintillation 
 
  
 
plate counter.
 
Results
 
Persistence and Expansion of MOG-reactive T Cells in the
CNS of CD24
 
 
 
/
 
  
 
But Not CD24
 
 
 
/
 
  
 
Mice.
 
Because CD24
is known to modulate the VLA4–VCAM-1 interaction (16),
an attractive hypothesis is that CD24 may determine the
pathogenicity of autoreactive T cells by controlling their re-
cruitment to the CNS. To test this hypothesis, we injected
MOG peptide–immune CD24
 
 
 
/
 
  
 
T cells into WT or
CD24-deficient mice and followed the clinical scores in the
recipient mice. In addition, the T cells in the brain were an-
alyzed by flow cytometry and quantitative RPA.
The T cells used were of the Th1 cell type as they pro-
duced IFN-
 
 
 
, but not IL-4, in response to MOG peptide
stimulation in vitro (unpublished data). As shown in Fig. 1
A, when we adoptively transferred MOG peptide–acti-
Figure 1. CD24 is required for persistence but not recruit-
ment of autoreactive T cells in the EAE model. (A) CD24 / 
recipient mice are resistant to EAE induced by adoptively
transferred T cells. WT and CD24 /   mice (five per
group) received 10   106 MOG peptide–activated lymph
node cells i.v. The clinical signs were scored daily. The
data shown are means and SD of EAE scores at different
times after adoptive transfer and are representative of three
independent experiments. (B) Migration of adoptively
transferred T cells into the brain of WT and CD24 / 
mice. A MOG-immune T cell line prepared from Thy1.1
congenic mice was adoptively transferred into WT or
CD24 /  hosts. At 3 d after adoptive transfer, the brains
were perfused with PBS and single cell suspensions were
analyzed by FACS® using anti-Thy1.1 and anti-CD4 anti-
bodies. Data shown have been repeated at least three times. 
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vated draining lymph node cells into CD24
 
 
 
/
 
  
 
syngeneic
recipient mice, all mice developed EAE at 
 
 
 
12–14 d after
cell transfer. The clinical scores peaked at 
 
 
 
18 d after T
cell transfer and declined gradually over the next 3 wk. In
contrast, none of the CD24
 
 
 
/
 
  
 
recipient mice developed
EAE, which is in agreement with our previous report (9).
Because CD24 reportedly modulates the interaction be-
tween VLA4 and VCAM-1 (16), we tested whether ex-
pression of CD24 in the host is required for T cell migra-
tion into the CNS. We generated MOG-specific T cells
from Thy1.1 congenic mice and adoptively transferred
them into WT and CD24
 
 
 
/
 
  
 
hosts. Based on published ob-
servations by others, most of the adoptively transferred T
cells migrate into the CNS by the third day after adoptive
transfer (1–3). Therefore, we harvested recipient brains af-
ter perfusion at 3 d after adoptive transfer and analyzed the
number of T cells by flow cytometry. As shown in Fig. 1
B, despite their low percentages, a well-defined population
of donor cells was found in the brains of WT recipients.
The same subset was found in the CD24
 
 
 
/
 
  
 
brains at a
comparable frequency. Thus, CD24 expression in the host
is not required for T cell migration into the brain.
We used RPA to measure the amount of T cells in the
brain. At various time points after adoptive transfer of T
cells, groups of two mice were perfused with PBS through
the left heart ventricle immediately after death, and the
brains were harvested for RNA isolation. Expression of
several T cell–specific genes was determined by RPA. As
directly shown in Fig. 2, CD3 and CD4 mRNA were un-
detectable in the CNS of normal CD24
 
 
 
/  and CD24 / 
mice that received no transfer, which was expected. By day
8 after the adoptive transfer, weak but significant signals for
the T cell–specific genes were detected in both groups of
recipients. High and comparable amounts of CD3 and
CD4 mRNA transcripts were detected on days 10–12 after
T cell transfer, again in both groups. In the CD24 /  brain,
the amount of T cells continued to rise on day 20 and re-
mained detectable on day 40 after the adoptive transfer. In
contrast, the T cells were greatly reduced on day 20 and
became undetectable by day 40 in the CD24 /  brain. The
majority of the T cells in the brain belonged to the CD4
subset, as the CD4 mRNA was more abundant than that of
CD8. Thus, the autoreactive T cells persist and expand in
CD24 /  but not in the CD24 /  CNS. These data dem-
onstrate a critical role of CD24 in sustaining T cells in the
CNS. The mRNA for macrophage marker F4/80 also in-
creased with that of CD3 and CD8, consistent with an on-
going T cell–initiated inflammation in the host.
It has been established that in the adoptive transfer
model, the host T cells are also recruited into the CNS af-
ter initiation of inflammation by the donor T cells (22, 23).
To distinguish the adoptively transferred T cells versus T
cells that were nonspecifically recruited into the CNS sec-
ondary to the antigen-specific T cells, we immunized
Thy1.1 congenic mice and immune lymph node cells were
cultured in the presence of MOG peptide and IL-12 for
4 d. The T cells were mostly of Th1 cell type, as the major-
ity of them produced IFN-  in response to PMA and iono-
mycin, although a small portion of T cells were capable of
producing IL-4 (unpublished data). After adoptive transfer
of these cells into either CD24 /  or CD24 /  recipient
mice, we could detect Thy1.1  T cells in the CNS of both
CD24 /  and CD24 /  mice on day 10 after transfer (Fig.
3). The immunohistochemical analysis of Thy1.1  T cells
revealed several interesting points. First, despite comparable
levels of CD3 mRNA in the brains of WT and CD24 / 
mice, a significant difference was observed in the number
of Thy1.1  T cells (Fig. 3, A–D). Second, in addition to
the difference in the number of Thy1.1  T cells, there was
also a significant difference in their distribution. In the WT
host, a substantial number of T cells were found in the
brain parenchyma. In contrast, essentially all of the donor T
cells were localized in the meninges and perivascular re-
gions in the CD24 /  brain and spinal cord. Third, as
shown in Fig. 3 E, the donor T cells appeared in clusters in
Figure 2. Quantitation of T cells in the brains of WT and CD24 / 
mice. (A) RPA. Mice that had received MOG-specific T cell transfers
were killed at the indicated time points. Immediately after death, the mice
were perfused with PBS through the left heart ventricle to wash blood out
of the brain. The brain was removed and total RNA was isolated by the
Trizol method. Each lane represents RNA samples mixed from two indi-
vidual mice at a 1:1 ratio. A total of 20  g RNA was used per lane. Data
are representative of four independent experiments. (B) Quantitation of
the relative amount of T cells based on intensity of the CD3 bands shown
in A. Intensity in the negative control samples was artificially set as 1.0.Bai et al. 451
the WT CNS. In the CD24 /  hosts, the donor cells rarely
formed clusters.
Reduced Local Proliferation in the CNS of the CD24 / 
Mice. The failure of CD3  T cells to persist in the CNS of
CD24 /  mice could be due to reduced proliferation of
CD24 /  T cells, or due to accelerated apoptosis of T cells.
To address this issue, we adoptively transferred MOG-spe-
cific Thy1.1 congenic T cells into CD24 /  and CD24 / 
mice, and determined the proliferation of the donor T cells
by a pulsing of BrdU on days 3–20 after T cell transfer. 12 h
after BrdU injection, the recipients were killed and perfused
through the left ventricle to avoid blood contamination in
the CNS. Mononuclear cells were isolated from the brain,
spinal cord, and spleen, and stained for BrdU incorporation.
As shown in Fig. 4 A, on day 3 after T cell transfer,
comparable numbers of Thy1.1  T cells were detected in
the spleens of both CD24 /  and CD24 /  mice (0.45 vs.
0.57% of total lymphocytes). These cells were undergoing
vigorous proliferation, as 19.1 versus 23% of Thy1.1  T
cells were incorporating BrdU within 12 h. At this point,
0.39 and 0.33% of Thy1.1  T cells were detected among
the CNS mononuclear cells of CD24 /  and CD24 / 
mice, respectively. Interestingly, in WT mice, 43.2% of
Thy1.1  T cells were incorporating BrdU in the CNS of
WT mice. This is more than twofold higher than those
Thy1.1  T cells in the spleen, presumably reflecting the ef-
fect of local antigen stimulation in the CNS. However,
only 27.1% of Thy1.1  T cells in the CD24 /  mouse
brains were BrdU . Because the rate of BrdU incorpora-
tion in the CNS is comparable to that of the spleen, it is
less clear to what extent their proliferation was in response
to stimulation in the periphery or in the CNS, as T cells are
known to be able to continue their proliferation if a thresh-
old proliferation has been observed (24).
By day 12 after T cell transfer, fewer donor T cells were
detected in the CD24 /  spleen than in the CD24 / 
spleen (0.8% in CD24 /  mice vs. 0.018% in CD24 / 
mice). About 2% of Thy1.1  T cells in the CD24 /  spleen
were BrdU . However, none of the Thy1  T cells in the
CD24 /  spleen were incorporating BrdU in the spleen.
We observed a significant increase in the number of
Thy1.1  T cells in both CD24 /  and CD24 /  CNS on
day 12 compared with day 3. More than 4% of the donor T
cells in the CD24 /  mouse brain were actively incorpo-
rating BrdU, whereas only 1.5% of donor T cells under-
went division in the CD24 /  mouse brain. Similar differ-
ences were observed in the T cells isolated from the spinal
cord (unpublished data). The significance of CD24-medi-
ated T cell clonal expansion is further substantiated by a
 10-fold difference in the number of T cells accumulated
Figure 3. CNS infiltration of the MOG-activated
T cells from Thy1.1 congenic mice. MOG peptide–
activated Thy1.1  T cells were injected into either
CD24 /  or CD24 /  recipient mice, and 160 ng
of pertussis toxin was injected i.v. at the time of T
cell transfer at 48 h. On day 10 after T cell transfer,
the mice were killed and frozen brain tissue sections
were prepared and stained with anti-Thy1.1 anti-
body. A and B represent brain sections of two indi-
vidual WT mice that received T cell transfer, and C
and D represent those two CD24 /  mice that re-
ceived MOG peptide–activated Thy1.1  T cells.
Magnification: A–D, 50; E, 200. Data shown are
representative of three independent experiments in-
volving a total of five mice per group.CD24 and T Cell Expansion in the Central Nervous System 452
in CD24 /  (26%) versus CD24 /  (2%) mouse brains on
day 12.
A comparison between the total number of T cells in the
CNS detected by RPA (Fig. 2) and those detected by
Thy1.1-specific antibody in both immunohistochemistry
(Fig. 3) and flow cytometry (Fig. 4 A) suggests that the
overwhelming majority of T cells detected by RPA in the
CD24 /  mouse brain are of host origin. This is confirmed
by flow cytometry, which revealed that more than  95%
of T cells in the CD24 /  mouse brain are of host origin,
whereas about an equal number of host and donor cells
were found in the CD24 /  brain (Fig. 4 B).
Local Activation and Apoptosis of T Cells in the CNS. In
addition to proliferation, a major factor that determines the
number of T cells is apoptosis. To test whether the lack of
T cell persistence in the CNS of CD24 /  mice is due to
accelerated cell death, we stained CNS-infiltrating cells for
apoptosis markers 7-AAD and annexin V, as shown in Fig.
5. On day 10 after T cell transfer,  30% of Thy1.1  brain-
infiltrating T cells were undergoing apoptosis in both
CD24 /  and CD24 /  mice. More than 50% of Thy1.1 
T cells were undergoing apoptosis in the spinal cords in
both CD24 /  and CD24 /  mice. However, no differ-
ence was observed between WT and CD24 /   hosts.
Thus, the failure of T cell persistence in the CNS of
CD24 /  mice is not due to accelerated T cell apoptosis.
Because expression of cytokines in the CNS is widely
used to measure T cell activation in situ (25), we used the
RPA assay to measure inflammatory cytokine mRNA ex-
Figure 4. Requirement for CD24
for optimal T cell proliferation in the
CNS. WT and CD24 /  mice adop-
tively transferred with congenic T
cells received an i.p. injection of
BrdU (1 mg/mouse) 12 h before
they were killed. Immediately after
death, the mice were perfused with
PBS through the left heart ventricle.
The brain, spinal cord, and spleen
were removed, and mononuclear
cells were prepared and stained for
Thy1.1 marker and BrdU incorpo-
ration. (A) BrdU incorporation in
antigen-specific donor T cells. Data
shown are profiles of gated Thy1.1 
T cells. The percentage of donor T
cells among mononuclear cells in the
spleen or brain is presented in the pa-
rentheses on top of each panel, and
the proportion of BrdU  T cells are
indicated underneath the gates. (B) T
cell accumulation in the CNS at day
12 after T cell transfer. Note that
both donor-derived and host-derived
T cells accumulated in the CNS.
The substantially reduced incorpora-
tion of BrdU and the accumulation
of donor cells in the brain of CD24 / 
mice have been reproduced in three
independent experiments.
Figure 5. Antigen-specific T cells undergo apoptosis at similar rates in
WT and CD24 /  CNS. MOG peptide–activated Thy1.1  T cells were
injected into either CD24 /  or CD24 /  recipient mice, and 160 ng of
pertussis toxin was injected i.v. at the time of T cell transfer and at 48 h. On
day 10 after T cell transfer, mice were killed and CNS-infiltrating cells were
prepared as described in Fig. 3. The CNS mononuclear cells were triple
labeled for Thy1.1, 7-AAD, and annexin V markers, as described in Materials
and Methods. Data presented here are gated on Thy1.1  T cells. Two inde-
pendent experiments were performed with similar results.Bai et al. 453
pression in the CNS. As shown in Fig. 6, although little
IFN- , TNF- , TNF- , and TGF-  were detected in both
CD24 /  and CD24 /  CNS on day 8 after T cell transfer,
significant up-regulation of all of these cytokine genes was
detected in WT mouse brains on days 10 and 12. With a
notable exception of TNF- , significant induction of IFN- ,
TNF- , and TGF-  was also observed in the CD24 / 
brains, although the overall levels were somewhat lower
than in the WT mice. The reduction in cytokine mRNA
that can be attributable to CD24 deficiency was not as dras-
tic as that in the number of donor T cells, perhaps because
some of the host T cells also synthesize cytokine mRNA.
CD24-deficient CNS APCs Have Reduced Capacity to
Stimulate Proliferation of Autoreactive T Cells. Because T
cells proliferated less in the CNS of CD24 /  recipient
mice, we reasoned that CD24 may contribute to EAE de-
velopment by regulating the functions of the CNS APCs.
To test this hypothesis, we compared astrocytes and micro-
glia from brains of newborn CD24 /  or CD24 /  mice
for their ability to stimulate WT T cells. As shown in Fig. 7
A, essentially all of the cells in the astrocyte culture ex-
pressed GFAP. CD24 /  astrocytes constitutively expressed
CD24, and after stimulation with IFN- , the level of
CD24 increased about threefold. The levels of CD80 and
CD86 were low even after IFN-  stimulation. As previ-
ously reported by others (19, 26), IFN-  induced signifi-
cant expression of MHC class I and II in both groups.
Although both groups of astrocytes stimulated prolifera-
tion of these T cells, WT astrocytes were approximately
fourfold more efficient in inducing the proliferation than
the CD24 /  astrocytes on a cell to cell basis (Fig. 7 B).
When the MOG peptide was titrated, the WT astrocytes
were again about fourfold more potent. The enhanced
proliferation was blocked by the addition of an anti-CD24
antibody, 20C9 (Fig. 7 C), which is known to block the
costimulatory activity of the CD24 molecule (13).
We also isolated microglia cells from newborn CD24 / 
or CD24 /  mice. As shown in Fig. 8 A, comparable levels
of the CD24 /  and CD24 /  microglia were strongly
positive for isolectin IB4 staining and CD45 (not depicted;
references 27 and 28). CD24 /  microglia constitutively
expressed high levels of CD24 and after stimulation with
IFN- , they expressed even higher levels of CD24. IFN- 
induced significant expression of MHC class I and II and
low levels of CD80 and CD86 on microglia. To compare
the costimulatory activity of the CD24 /  and CD24 / 
microglia cells, we stimulated MOG-specific T cell lines
with these cells in the presence of different concentrations
of MOG peptide. Based on the titration of antigen, WT
microglia were approximately fivefold more efficient in in-
ducing T cell proliferation (Fig. 8 B). These results suggest
that CD24 expressed on microglia can promote prolifera-
tion of MOG-reactive T cells.
Expression of CD24 on Radiosensitive and Radioresistant
Host Cells Confers Susceptibility to Pathogenic T Cells in the
CNS. The resistance of the CD24 /  mice to EAE in-
duction by WT T cells suggests that at least some host cells
are required to express CD24. Because local APCs can be
of either hematopoietic or nonhematopoietic origin, we
created radiation bone marrow chimeras to determine
whether expression of CD24 on hematopoietic cells is suf-
ficient to convey EAE susceptibility. As shown in Fig. 9 A,
a single round of bone marrow transplantation resulted in
an essentially complete replacement of CD24-expressing
cells in the spleen, which demonstrates the efficacy of irra-
diation. Reciprocal chimeras were used to determine the
nature of the host cells required for EAE susceptibility,
whereas syngeneic chimeras were used as controls.
As shown in Fig. 9 B, all CD24 /    CD24 /  bone
marrow chimeras developed EAE after CD24 /  T cell
Figure 6. Cytokine gene expression in brains of WT and CD24 / 
mice on days 8, 10, and 12 after adoptive transfer of T cells. (A) An auto-
radiograph of a representative RPA. (B) Quantitation of the relative
abundance of cytokine mRNA. The intensity of bands were normalized
with L32 to avoid variations of total RNA used. The mRNA level on
day 8 in the WT mouse brains is defined as 1.0. The data presented are
representative of three experiments. The samples used in this figure are
the same as those used in Fig. 2.CD24 and T Cell Expansion in the Central Nervous System 454
Figure 7. CD24 /  CNS astrocytes
had a reduced capacity to stimulate
MOG-specific T cell proliferation. (A)
Characterization of astrocytes prepared
from newborn CD24 /  and CD24 / 
littermates. GFAP was stained after per-
meabilization and the intact cells were
used for analysis of other markers. Red
lines and black lines represent profiles of
fluorescence intensity of CD24 /  astro-
cytes when stained with either specific
antibodies (red) or controls (black), and
blue lines (specific staining) and green
lines (control staining) depict the fluo-
rescence intensity of CD24 /   astro-
cytes, as indicated by arrows. CD24
staining of IFN- –treated and –untreated
astrocytes is shown, whereas only IFN- –
stimulated astrocytes were analyzed for
CD80, CD86, Db, and I-Ab expression.
(B) The MOG-reactive T cell line (5  
104/well) was stimulated by serial ti-
trated astrocytes in the presence of 50
 g/ml MOG peptide. Data are repre-
sentative of two independent experi-
ments with similar results. (C) Blocking
of T cell proliferation by CD24-specific
antibody. CD24 /  or CD24 /  astro-
cytes were irradiated (3,000 rads) and
seeded into U-bottomed 96-well plates
in DMEM culture medium containing
100 U/ml IFN- . 3 d later, medium
was discarded and a T cell line specific
for MOG peptide was added into the
indicated wells at a concentration of 2.5   104/well in the presence of given concentrations of MOG peptide. Anti-CD24 mAb 20C9 and a control
hamster IgG were used at 1  g/ml. Data are means and SD of cpm and are representative of three experiments.
Figure 8. CD24 /  CNS mi-
croglia had a reduced capacity to
stimulate MOG-specific T cell
proliferation. (A) Characterization
of microglia prepared from new-
born CD24 /   and CD24 / 
mice. Microglia preparation was
either left untreated or stimu-
lated with 100 U/ml IFN-  for
48 h. Cell surface IB4, CD80,
CD86, Db, and I-Ab were ana-
lyzed by flow cytometry. Red
lines and black lines represent
profiles of fluorescence intensity
of CD24 /   astrocytes when
stained with either specific anti-
bodies (red) or controls (black),
and blue lines (specific staining)
and green lines (control stain-
ing) depict the fluorescence in-
tensity of CD24 /  astrocytes, as
indicated by arrows. (B) CD24 / 
brain microglia had a reduced
capacity to stimulate MOG-
specific T cell proliferation. Irra-
diated microglia were stimulated
with 100 U/ml IFN-  for 3 d
and were used to present MOG
peptide to a MOG-specific T
cell line (5   104/well). Data are
means and SD of cpm and are
representative of five individual
experiments.Bai et al. 455
transfer. In contrast, none of the CD24 /    CD24 /  re-
cipient chimeras were susceptible to pathogenic T cells. All
CD24 /    CD24 /  chimeras developed EAE with simi-
lar kinetics to that of the CD24 /     CD24 /  mice.
These results demonstrate that CD24 /  bone marrow–
derived cells corrected the local antigen presentation de-
fects in the CD24 /  mice. Interestingly, all CD24 /   
CD24 /  chimeras also developed EAE. Although the on-
set was delayed by  4 d in this experiment, the peak EAE
scores were equal to those observed in the CD24 /   
CD24 /  and CD24 /    CD24 /  chimera mice. Such
difference was, however, not always observed in subse-
quent experiments (unpublished data).
To rule out the possibility that the susceptibility of the
CD24 /    CD24 /  mice to EAE was due to resid-
ual  bone marrow–derived CD24 /  cells, we irradiated
CD24 /      CD24 /   chimera mice and reconstituted
them with CD24 /  bone marrow again. We then tested
whether these mice were sensitive to EAE induction by
WT MOG-specific T cell transfer. As shown in Fig. 9 C,
while CD24 /    CD24 /  mice were resistant to EAE
induction, CD24 /     CD24 /  mice developed EAE
with similar kinetics to those of CD24 /     CD24 / 
mice. However, both groups had a lower EAE score than
the CD24 /    CD24 /  mice did. It is therefore likely
that although WT bone marrow can convey EAE suscepti-
bility to CD24 /  mice, replacement with CD24 /  bone
marrow in WT mice does not abolish the EAE susceptibil-
ity of the CD24 /  mice. Thus, either hematopoietic or
nonhematopoietic CD24-expressing cells can confer sus-
ceptibility to pathogenic T cells in the CNS. However, it is
likely that the two cell types can act synergistically, as re-
vealed by the partial efficacy of a single cell type in recipi-
ents after two rounds of bone marrow replacement.
B cells constitutively express high levels of CD24. More-
over, a significant number of B cells were recruited into the
CNS during EAE development and regulated disease severity
and recovery (29, 30). Because activated B cells delivered
CD24-mediated costimulation (11), we investigated whether
B cells are the bone marrow–derived CD24 /  APCs that
convey EAE susceptibility. As shown in Fig. 9 D, CD24 / 
RAG-1 /    CD24 /  mice were fully susceptible to EAE
induction. Thus, CD24 expression on B cells is not required
for conveying EAE susceptibility to CD24 /  mice.
Discussion
We have previously demonstrated that CD24-deficient
hosts resist the pathogenic T cells adoptively transferred
from WT mice. Because resistance to the adoptively trans-
Figure 9. Expression of CD24
on either hematopoietic or non-
hematopoietic cells is sufficient
to confer susceptibility to adop-
tively transferred MOG-specific
T cells. (A) FACS® profiles of
bone marrow chimeras at 8 wk
after reconstitution. Splenocytes
were stained with FITC-labeled
anti-B220 and PE-conjugated
anti-CD24 antibodies. (B) In-
duction of EAE in bone marrow
chimeras. 40   106 MOG pep-
tide–activated lymph node cells
were injected into mice that
were irradiated (350 rads) 1 h
before receiving pathogenic T
cells. Data are means and SEM of
EAE score in groups of four
mice each and are representative
of three independent experiments
with similar results. (C) EAE
susceptibility in double radia-
tion chimeras. Mice numbers in
each group: WT   WT, n   4;
 /     / , n   4; WT  
 / , n   3;  /    WT, n   3.
Data are representative of two
independent experiments. (D)
CD24 /  RAG-1 /    CD24 / 
mice are fully sensitive to EAE
induction. For induction of
EAE, 50   106/mouse of T cells
were used. Mice numbers in
each group: WT    / , n   4;
 /     / , n   4; RAG-
1 /     / , n   5. Data are
pooled from two experiments.CD24 and T Cell Expansion in the Central Nervous System 456
ferred T cells was observed when the hosts were immune
suppressed by irradiation before adoptive transfer (9), it is
likely that the resistance is not due to host immunity to
adoptively transferred T cells. To avoid complications asso-
ciated with homeostatic proliferation in an irradiated host,
we reproduced the above observation in nonirradiated re-
cipients and followed the recruitment and local activation
of autoreactive T cells in the CNS during EAE. The data
presented here make three points.
CD24 Expression in the Host Is Required for T Cell Persis-
tence in, But Not Recruitment to, the CNS. Our previous
studies have demonstrated that expression of CD24 on host
cells is critically important for the development of EAE (9).
Because CD24 was not required for the priming of autore-
active T cells (9), and because CD24 was reported to mod-
ulate VLA4 interaction with VCAM-1 (16), which is
known to be required for T cell recruitment (17), we
tested whether CD24 is critical for the recruitment of T
cells to the CNS by immunohistochemistry, RPA, and
flow cytometry.
At 3 d after adoptive transfer, a similar number of
Thy1.1  donor cells were detected in the CNS of both
CD24 /  and CD24 /  recipients. On day 12, the number
of donor T cells in the CNS was substantially less in
CD24 /  mice in comparison to WT mice. However, the
number of CD3  T cells recruited to the CNS was compa-
rable in the two groups, as revealed by quantitative RPA,
largely due to recruitment of host T cells. These results
demonstrate that expression of CD24 in the CNS is not re-
quired for T cell migration into the CNS, regardless of
their origin.
Despite the lack of a significant difference in T cell re-
cruitment, we observed major differences in the persistence
of autoreactive T cells in the CNS. By day 12, the number
of donor T cells was reduced by 10-fold in the CD24 / 
brain in comparison to WT recipients. The reduction of do-
nor autoreactive T cells was followed by a disappearance of
bystander host T cells, such that no T cells were detected in
the CD24 /  mouse brain at a time when the WT brain had
seen a significant increase in total T cells. Thus, CD24 ex-
pression is required for the persistence of both antigen-spe-
cific donor cells and host T cells with unknown specificity.
A potential caveat associated with the adoptive transfer
experiment is that the CD24 may serve as a rejection anti-
gen when the WT T cells are injected into the CD24 / 
host. We performed two types of experiments to rule out
this possibility. First, we obtained serum from CD24-defi-
cient hosts at 3 wk after they received WT T cells, and
then tested for the presence of anti-CD24 antibodies. No
such antibodies could be detected in the serum (unpub-
lished data). Second, at 3 wk after adoptive transfer, we
reinjected carboxyfluorescein succinimidyl ester–labeled,
MOG-reactive WT T cells into the WT and CD24 /  re-
cipient that had been “primed” by the previous round of
adoptive transfer and determined the amounts of donor
cells in the two types of recipients. The analysis indicated
that CD24 /  recipients did not preferentially eliminate the
donor T cells (unpublished data). Both approaches suggest
that it is highly unlikely that the failure of WT T cells to
persist in the CD24 /  CNS is due to host immunity spe-
cific for CD24.
The Rate of Local Expansion of Autoreactive T Cells in the
CNS Is Controlled by CD24. Theoretically, the differen-
tial persistence of T cells in the WT and CD24 /  hosts
can be attributed to two different factors. The first is the lo-
cal expansion of T cells and the second is their pro-
grammed cell death. It is well established that the T cells in
the CNS are prone to programmed cell death (4–7). How-
ever, it is unknown whether T cells clonally expand in the
CNS and if so, whether CD24 plays a role in this process.
Using a short-term BrdU labeling in vivo, we were able
to clearly demonstrate substantial T cell division in the
CNS of WT mice. Because the antigen-specific T cells mi-
grated into the CNS en masse shortly after adoptive transfer
(1), and more importantly, because the rate of T cell divi-
sion was substantially higher in the CNS than in the spleen,
it is likely that the majority of BrdU incorporation in the
CD24 /  CNS took place locally. In contrast, even though
the donor T cells divided at a slightly higher rate in the
spleen of CD24 /  recipients than the WT counterpart on
day 3, the rate of division in the CD24 /  CNS was less
than that in the WT CNS. The reversion of the relative
BrdU incorporation rates between the spleen and the CNS
of the two strains of mice reveals two interesting points.
First, the BrdU incorporation in the CNS reflects local T
cell proliferation, and second, CD24 plays a critical role in
the process. Consequently, the number of donor T cells
was  10-fold higher in the WT CNS on day 12 when the
total numbers of T cells in CNS were comparable between
WT and CD24 /  mice.
Our study extends the elegant work by Flugel et al. (1),
who reported de novo expression of activation markers on
autoreactive T cells after migration into the CNS. It is of in-
terest to note that these authors also showed, in an adoptive
transfer model of EAE, that T cell migration into the CNS is
complete within 3 d of adoptive transfer. Given the rapid T
cell death seen in WT CNS (4–7), it is highly likely that a
more rapid T cell clonal expansion is required for a sustained
immune response. Our study indicated that by controlling
the efficacy of this process, CD24 expression on host cells
constitutes a major checkpoint of EAE pathogenesis.
Two Lineages of CD24-expressing APCs in CNS. Rec-
ognition of CNS autoantigen is considered a prerequisite
for the initiation of T cell–mediated CNS inflammation (2,
3). Recent evidence suggests that local antigen processing
and presentation in the CNS is essential for EAE develop-
ment because mice deficient for Ii and H-2M failed to de-
velop EAE (31). Because our work established the impor-
tance of local T cell clonal expansion, it also raised the
possibility that T cell costimulation might be required for
the process.
Our comparison of T cell proliferation in CD24 /  and
CD24 /  recipients demonstrates that CD24 is required for
optimal local T cell clonal expansion in the CNS. In sup-
port of this hypothesis, we also demonstrated that activation
of T cells by astrocytes and microglia in vitro depends onBai et al. 457
CD24, as CD24 /  APCs are substantially more efficient in
inducing T cell proliferation, and that proliferation of
CD24 /  astrocytes are blocked by an anti-CD24 antibody.
Our bone marrow chimera experiments revealed that
expression of CD24 on one of the two lineages of APCs is
sufficient for EAE development. One of the two is bone
marrow derived. Expression of CD24 on B cells was un-
necessary, as bone marrow from RAG-1–deficient mice
was equally competent as WT bone marrow. Although no
genetic model is available to define other cell lineages as the
potential local APC, our in vitro analysis demonstrated that
the ability of microglia to present antigen to T cells is di-
minished if the CD24 gene is defective. Because perivas-
cular microglia, although not parenchyma microglia, are
mainly bone marrow derived (32, 33), it is possible that this
lineage of the microglia is the radiosensitive bone marrow–
derived APC.
Interestingly, we also found that CD24 expression on ra-
dioresistant cells in the host was sufficient to convey EAE
susceptibility. This is not due to incomplete depletion of
radiosensitive cells, as the same conclusion was reached af-
ter two rounds of irradiation. The identity of the radioresis-
tant cells is unknown. However, at least two candidates can
be proposed from our in vitro data. The first is the paren-
chyma microglia that have been shown to be radioresistant
(34, 35), and the other is astrocytes. Both cell types consti-
tutively express CD24, which can be further elevated by
inflammatory cytokines such as IFN- . Moreover, both
cell types require the CD24 gene for optimal induction of
T cell proliferation in vitro.
In summary, we have shown that CD24 is a novel
checkpoint for local clonal expansion of T cells in the
CNS. Because there is no difference in apoptosis of donor
T cells, the defective proliferation in the CD24 /  CNS is
likely the primary cause for the drastic reduction of donor
T cells at the time when clinical signs of EAE were ob-
served. The lack of effect on T cell apoptosis indicated that
the function of CD24 differs from B7-1 and B7-2 (36).
However, it should be pointed out that this study has not
definitively proven that defective proliferation alone pre-
vented the induction of EAE in the adoptive transfer
model. CD24 may mediate other functions essential for
EAE development. For instance, the transferred autoreac-
tive T cells reside primarily in the meninges in CD24 / 
mice, whereas many of them migrate into the brain paren-
chyma in WT mice. The significance of this observation is
unknown at this point, nor is it clear if this is a direct con-
sequence of defective T cell proliferation. Nevertheless,
given the high death rate of T cells in the CNS, it is highly
likely that a gene that controls the rate of proliferation of
autoreactive T cells in the CNS may play an essential role
for pathogenesis. This checkpoint might be particularly rel-
evant for immunotherapy of MS for two reasons. First, this
checkpoint controls the function of T cells after they are
primed and have migrated to the CNS. This resembles a
clinical setting, as patients who seek care already have au-
toreactive T cells in the lymphoid organ and/or in the
CNS. Second, the significance of CD24 in MS is demon-
strated by our recent observation that CD24 polymorphism
in the human is a genetic modifier for the risk and progres-
sion of MS (10).
We thank Lynde Shaw and Beth McNally for editorial assistance.
This work is supported by grants from the National Institutes of
Health (NIH; AI 32981 and NS46696 to Yang Liu and NS41692
to Q. Zhou) and a grant from the Department of Defense to P.
Zheng. X.F. Bai was supported by an advanced postdoctoral fel-
lowship from the National Multiple Sclerosis Society.
P. Zheng and Yang Liu are founders and have equity interest in
OncoImmune, Ltd., which is a recipient of NIH grant NS41692.
Submitted: 21 January 2004
Accepted: 1 July 2004
References
1. Flugel, A., T. Berkowicz, T. Ritter, M. Labeur, D.E. Jenne,
Z. Li, J.W. Ellwart, M. Willem, H. Lassmann, and H. Wek-
erle. 2001. Migratory activity and functional changes of
green fluorescent effector cells before and during experimen-
tal autoimmune encephalomyelitis. Immunity. 14:547–560.
2. Wekerle, H., D. Sun, R.L. Oropeza-Wekerle, and R. Mey-
ermann. 1987. Immune reactivity in the nervous system:
modulation of T-lymphocyte activation by glial cells. J. Exp.
Biol. 132:43–57.
3. Hickey, W.F. 1991. Migration of hematogenous cells through
the blood-brain barrier and the initiation of CNS inflamma-
tion. Brain Pathol. 1:97–105.
4. Pender, M.P., K.B. Nguyen, P.A. McCombe, and J.F. Kerr.
1991. Apoptosis in the nervous system in experimental aller-
gic encephalomyelitis. J. Neurol. Sci. 104:81–87.
5. White, C.A., P.A. McCombe, and M.P. Pender. 1998. The
roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the
central nervous system in experimental autoimmune enceph-
alomyelitis. J. Neuroimmunol. 82:47–55.
6. Schmied, M., H. Breitschopf, R. Gold, H. Zischler, G. Rothe,
H. Wekerle, and H. Lassmann. 1993. Apoptosis of T lympho-
cytes in experimental autoimmune encephalomyelitis. Evi-
dence for programmed cell death as a mechanism to control
inflammation in the brain. Am. J. Pathol. 143:446–452.
7. Bauer, J., M. Bradl, W.F. Hickley, S. Forss-Petter, H.
Breitschopf, C. Linington, H. Wekerle, and H. Lassmann.
1998. T-cell apoptosis in inflammatory brain lesions: destruc-
tion of T cells does not depend on antigen recognition. Am.
J. Pathol. 153:715–724.
8. Rougon, G., L.A. Alterman, K. Dennis, X.J. Guo, and C.
Kinnon. 1991. The murine heat-stable antigen: a differentia-
tion antigen expressed in both the hematolymphoid and neu-
ral cell lineages. Eur. J. Immunol. 21:1397–1402.
9. Bai, X.F., J.Q. Liu, X. Liu, Y. Guo, K. Cox, J. Wen, P.
Zheng, and Y. Liu. 2000. The heat-stable antigen determines
pathogenicity of self-reactive T cells in experimental autoim-
mune encephalomyelitis. J. Clin. Invest. 105:1227–1232.
10. Zhou, Q., K. Rammohan, S. Lin, N. Robinson, O. Li, X.
Liu, X.F. Bai, L. Yin, B. Scarberry, P. Du, et al. 2003. CD24
is a genetic modifier for risk and progression of multiple scle-
rosis. Proc. Natl. Acad. Sci. USA. 100:15041–15046.
11. Liu, Y., B. Jones, A. Aruffo, K.M. Sullivan, P.S. Linsley, and
C.A. Janeway, Jr. 1992. Heat-stable antigen is a costimulatory
molecule for CD4 T cell growth. J. Exp. Med. 175:437–445.
12. Liu, Y., B. Jones, W. Brady, C.A. Janeway, Jr., P.S. Linsley,CD24 and T Cell Expansion in the Central Nervous System 458
and P.S. Linley. 1992. Co-stimulation of murine CD4 T cell
growth: cooperation between B7 and heat-stable antigen.
Eur. J. Immunol. 22:2855–2859.
13. Liu, Y., R.H. Wenger, M. Zhao, and P.J. Nielsen. 1997.
Distinct costimulatory molecules are required for the induc-
tion of effector and memory cytotoxic T lymphocytes. J.
Exp. Med. 185:251–262.
14. Zhou, Q., Y. Wu, P.J. Nielsen, and Y. Liu. 1997. Homo-
typic interaction of the heat-stable antigen is not responsible
for its co-stimulatory activity for T cell clonal expansion. Eur.
J. Immunol. 27:2524–2528.
15. Hubbe, M., and P. Altevogt. 1994. Heat-stable antigen/
CD24 on mouse T lymphocytes: evidence for a costimula-
tory function. Eur. J. Immunol. 24:731–737.
16. Hahne, M., R.H. Wenger, D. Vestweber, and P.J. Nielsen.
1994. The heat-stable antigen can alter very late antigen
4–mediated adhesion. J. Exp. Med. 179:1391–1395.
17. Baron, J.L., J.A. Madri, N.H. Ruddle, G. Hashim, and C.A.
Janeway, Jr. 1993. Surface expression of alpha 4 integrin by
CD4 T cells is required for their entry into brain paren-
chyma. J. Exp. Med. 177:57–68.
18. Nielsen, P.J., B. Lorenz, A.M. Muller, R.H. Wenger, F.
Brombacher, M. Simon, T. von der Weid, W.J. Langhorne,
H. Mossmann, and G. Kohler. 1997. Altered erythrocytes
and a leaky block in B-cell development in CD24/HSA-
deficient mice. Blood. 89:1058–1067.
19. Fierz, W., B. Endler, K. Reske, H. Wekerle, and A. Fontana.
1985. Astrocytes as antigen-presenting cells. I. Induction of
Ia antigen expression on astrocytes by T cells via immune in-
terferon and its effect on antigen presentation. J. Immunol.
134:3785–3793.
20. Giulian, D., and T.J. Baker. 1986. Characterization of ame-
boid microglia isolated from developing mammalian brain. J.
Neurosci. 6:2163–2178.
21. Brenner, M., W.C. Kisseberth, Y. Su, F. Besnard, and A.
Messing. 1994. GFAP promoter directs astrocyte-specific ex-
pression in transgenic mice. J. Neurosci. 14:1030–1037.
22. Hickey, W.F., B.L. Hsu, and H. Kimura. 1991. T-lympho-
cyte entry into the central nervous system. J. Neurosci. Res.
28:254–260.
23. Krakowski, M.L., and T. Owens. 2000. Naive T lymphocytes
traffic to inflamed central nervous system, but require antigen
recognition for activation. Eur. J. Immunol. 30:1002–1009.
24. van Stipdonk, M.J., G. Hardenberg, M.S. Bijker, E.E. Lem-
mens, N.M. Droin, D.R. Green, and S.P. Schoenberger.
2003. Dynamic programming of CD8  T lymphocyte re-
sponses. Nat. Immunol. 4:361–365.
25. Kawakami, N., S. Lassmann, Z. Li, F. Odoardi, T. Ritter, T.
Ziemssen, W.E. Klinkert, J.W. Ellwart, M. Bradl, K. Kri-
vacic, et al. 2004. The activation status of neuroantigen-spe-
cific T cells in the target organ determines the clinical out-
come of autoimmune encephalomyelitis. J. Exp. Med. 199:
185–197.
26. Massa, P.T., V. ter Meulen, and A. Fontana. 1987. Hyperin-
ducibility of Ia antigen on astrocytes correlates with strain-
specific susceptibility to experimental autoimmune encepha-
lomyelitis. Proc. Natl. Acad. Sci. USA. 84:4219–4223.
27. Grossmann, R., N. Stence, J. Carr, L. Fuller, M. Waite, and
M.E. Dailey. 2002. Juxtavascular microglia migrate along
brain microvessels following activation during early postnatal
development. Glia. 37:229–240.
28. Naujoks-Manteuffel, C., and U. Niemann. 1994. Microglial
cells in the brain of Pleurodeles waltl (Urodela, Salaman-
dridae) after wallerian degeneration in the primary visual sys-
tem using Bandeiraea simplicifolia isolectin B4-cytochemis-
try. Glia. 10:101–113.
29. Svensson, L., K.B. Abdul-Majid, J. Bauer, H. Lassmann,
R.A. Harris, and R. Holmdahl. 2002. A comparative analysis
of B cell-mediated myelin oligodendrocyte glycoprotein-
experimental autoimmune encephalomyelitis pathogenesis in
B cell-deficient mice reveals an effect on demyelination. Eur.
J. Immunol. 32:1939–1946.
30. Fillatreau, S., C.H. Sweenie, M.J. McGeachy, D. Gray, and
S.M. Anderton. 2002. B cells regulate autoimmunity by pro-
vision of IL-10. Nat. Immunol. 3:944–950.
31. Slavin, A.J., J.M. Soos, O. Stuve, J.C. Patarroyo, H.L.
Weiner, A. Fontana, E.K. Bikoff, and S.S. Zamvil. 2001.
Requirement for endocytic antigen processing and influence
of invariant chain and H-2M deficiencies in CNS autoimmu-
nity. J. Clin. Invest. 108:1133–1139.
32. Hickey, W.F., and H. Kimura. 1988. Perivascular microglial
cells of the CNS are bone marrow-derived and present anti-
gen in vivo. Science. 239:290–292.
33. Myers, K.J., J.P. Dougherty, and Y. Ron. 1993. In vivo anti-
gen presentation by both brain parenchymal cells and he-
matopoietically derived cells during the induction of ex-
perimental autoimmune encephalomyelitis. J. Immunol. 151:
2252–2260.
34. Rinner, W.A., J. Bauer, M. Schmidts, H. Lassmann, and
W.F. Hickey. 1995. Resident microglia and hematogenous
macrophages as phagocytes in adoptively transferred experi-
mental autoimmune encephalomyelitis: an investigation us-
ing rat radiation bone marrow chimeras. Glia. 14:257–266.
35. Hickey, W.F., K. Vass, and H. Lassmann. 1992. Bone mar-
row-derived elements in the central nervous system: an im-
munohistochemical and ultrastructural survey of rat chimeras.
J. Neuropathol. Exp. Neurol. 51:246–256.
36. Chang, T.T., R.A. Sobel, T. Wei, R.M. Ransohoff, V.K.
Kuchroo, and A.H. Sharpe. 2003. Recovery from EAE is as-
sociated with decreased survival of encephalitogenic T cells
in the CNS of B7-1/B7-2-deficient mice. Eur. J. Immunol.
33:2022–2032.